The Forgotten Brother: The Innate-like B1 Cell in Multiple Sclerosis

Saar T. Halperin, Bert A. ’t Hart, Antonio Luchicchi, Geert J. Schenk

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Scopus)

Abstract

Multiple sclerosis (MS) is a neurodegenerative disease of the central nervous system (CNS), traditionally considered a chronic autoimmune attack against the insulating myelin sheaths around axons. However, the exact etiology has not been identified and is likely multi-factorial. Recently, evidence has been accumulating that implies that autoimmune processes underlying MS may, in fact, be triggered by pathological processes initiated within the CNS. This review focuses on a relatively unexplored immune cell—the “innate-like” B1 lymphocyte. The B1 cell is a primarynatural-antibodyand anti-inflammatory-cytokine-producing cell present in the healthy brain. It has been recently shown that its frequency and function may differ between MS patients and healthy controls, but its exact involvement in the MS pathogenic process remains obscure. In this review, we propose that this enigmatic cell may play a more prominent role in MS pathology than ever imagined. We aim to shed light on the human B1 cell in health and disease, and how dysregulation in its delicate homeostatic role could impact MS. Furthermore, novel therapeutic avenues to restore B1 cells’ beneficial functions will be proposed.
Original languageEnglish
Article number606
JournalBiomedicines
Volume10
Issue number3
DOIs
Publication statusPublished - 1 Mar 2022

Keywords

  • Autoantibodies
  • Autoimmunity
  • B1 cell
  • Innate-like lymphocytes
  • Multiple sclerosis
  • Natural antibodies
  • Neurodegeneration

Cite this